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Systemic gene delivery systems are needed for therapeutic application to organs
that are inaccessible by percutaneous injection. Currently, the main objective is the
development of a stable and non-toxic vector that can encapsulate and deliver
foreign genetic material to target cells. To this end, DNA, complexed with cationic
lipids i.e. DOTAP/DOPE, was encapsulated into lipid nanocapsules (LNCs) leading to
the formation of stable nanocarriers (DNA LNCs) with a size inferior to 130 nm.
Amphiphilic and flexible poly (ethylene glycol) (PEG) polymer coatings [PEG lipid
derivative (DSPE-mPEG2000) or F108 poloxamer] at different concentrations were
selected to make DNA LNCs stealthy. Some of these coated lipid nanocapsules were
able to inhibit complement activation and were not phagocytised in vitro by
macrophagic THP-1 cells whereas uncoated DNA LNCs accumulated in the vacuolar
compartment of THP-1 cells. These results correlated with a significant increase of
in vivo circulation time in mice especially for DSPE-mPEG2000 10 mm and an early
half-life time (t1/2 of distribution) 5-fold greater than for non-coated DNA LNCs (7.1
h vs 1.4 h). Finally, a tumor accumulation assessed by in vivo fluorescence imaging
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